Surgical Wound Infection Prevention Bundle in Patients Undergoing Coronary Bypass Graft Surgery
Launched by SOHAG UNIVERSITY · May 26, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special set of practices, called a "surgical wound infection prevention bundle," designed to help prevent infections in patients undergoing coronary bypass graft surgery (CABG). CABG is a procedure that helps improve blood flow to the heart by using a blood vessel from another part of the body. The researchers want to see if these tailored practices can effectively reduce the risk of infection after the surgery.
To participate in this trial, patients must have coronary artery disease and may also have diabetes or high blood pressure. However, those with cancer, weakened immune systems, or other types of heart surgeries will not be eligible. While the trial is not yet recruiting participants, those who join can expect to follow the infection prevention practices during their care. This study aims to improve patient safety and outcomes for people undergoing heart surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • coronary artery disease ,diebetes mellitus,hypertension,
- Exclusion Criteria:
- • patients who have cancer , immunocompromised patients, cardiac surgeries other than CABG
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported